335 patents currently held
48 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Feb 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
20
Ending by 2030
Feb 2027
Next term end
276
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2040 · High confidence
Also notable
Ends Nov 2040 · High confidence
Also notable
Ends Sep 2031 · High confidence
Device for Automatically Inserting and Manipulating a Medical Tool into and Within a Bodily Lumen
US 11,291,515
Cited by 27 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2040.
Modular Robotic System for Driving Movement of Surgical Tools
US 11,241,291
Cited by 31 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2040.
Methods for Expanding and Maintaining Human Pluripotent Stem Cells (PSCS) in an Undifferentiated State in a Single Cell Suspension Culture
US 10,214,722
Cited by 25 later US patents, top 10% of utility patents granted in 2019 in our data. Protection runs to 2031.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 3 fees due Nov 21 to 28, 2026 · next Nov 21
- 4 fees due Dec 4 to 27, 2026 · next Dec 4
- 4 fees due Jan 4 to 30, 2027 · next Jan 4
- 9 fees due Feb 6 to 28, 2027 · next Feb 6
- 3 fees due Mar 3, 2027
- 12 fees due Apr 6 to 24, 2027 · next Apr 6
- 3 fees due May 3 to 28, 2027 · next May 3
- 7 fees due Jun 3 to 30, 2027 · next Jun 3
- 7 fees due Jul 5 to 30, 2027 · next Jul 5
- 4 fees due Aug 18 to 27, 2027 · next Aug 18
- 6 fees due Sep 12 to 30, 2027 · next Sep 12
- 8 fees due Oct 2 to 30, 2027 · next Oct 2
- 4 fees due Nov 5 to 12, 2027 · next Nov 5
Recent changes
- Nov 12Assignment recorded on 1 record: Bar-Lev, Daniella and 3 others to Technion Research & Development Foundation Limited Recorded Nov 12, 2026, executed Aug 19, 2023. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76730, frame 133.
- Oct 13Assignment recorded on US 10,309,958: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. to Technion Research & Development Foundation Limited Recorded Oct 13, 2026, executed Sep 9, 2026. Conveyance as recorded: Assignment of Assignor's Interest. A recorded assignment is a filed document, not a statement of current ownership. Reel 76345, frame 458.
- 16 of the patents on this record were granted since Aug 17, 2026
- 13 terms have ended since Aug 17, 2026
What they patent
The 5 largest of its 276 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Aminoglycosides and Uses Thereof in Treating Genetic Disorders | 7 in force | to Nov 2031 |
| Methods for Expanding and Maintaining Human Pluripotent Stem Cells (PSCS) in an Undifferentiated State in a Single Cell Suspension Culture | 5 in force | to Aug 2034 |
| Heat Engine | 3 in force | to Sep 2041 |
| Terrestrially Observable Displays from Space | 3 in force | to Nov 2037 |
| Neuronal Modulation | 3 in force | to May 2035 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,572,908 | Novel Manufacturing and Applications of Adhesive Materials In force · Medium confidence | In force | Medium confidence | |
| US 10,159,689 | Novel Aminoglycosides and Uses Thereof in the Treatment of Genetic Disorders In force · Medium confidence | In force | Medium confidence | |
| US 9,404,079 | Media for Culturing Stem Cells In force · Medium confidence | In force | Medium confidence | |
| US 9,834,749 | Methods of Expanding Embryonic Stem Cells in a Suspension Culture In force · Medium confidence | In force | Medium confidence | |
| US 12,391,918 | Media for Culturing Stem Cells In force · Medium confidence | In force | Medium confidence | |
| US 8,551,948 | Albumin Fibers and Fabrics and Methods of Generating and Using Same In force · Medium confidence | In force | Medium confidence | |
| US 8,513,194 | Compositions Comprising Semaphorins for the Treatment of Angiogenesis Related Diseases and Methods of Selection Thereof In force · Medium confidence | In force | Medium confidence | |
| US 8,871,276 | Beta-Casein Assemblies for Mucosal Delivery of Therapeutic Bioactive Agents Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 10,132,776 | PH Gradients Controlled by Electrolysis, and Their Use in Isoelectric Focusing In force · Medium confidence | In force | Medium confidence | |
| US 8,531,457 | Apparatus and Method for Finding Visible Points in a Cloud Point In force · High confidence | In force | High confidence |
Also on record, not counted in the 335: 48 patents in force now held by others · 161 patents ended · 197 applications pending · 167 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.